Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, April 23, 2025

View Back issues

Pfizer Demands JAMA's Notes On Celebrex

CHICAGO (CN) – **Pfizer asked the Federal Court to order nonparties **The American Medical Association and the Journal of The American Medical Association to turn over “peer review comments, draft manuscripts, and correspondence with the authors” of articles about Celebrex and Bextra. The JAMA is willing to turn over only the published articles. See filing in Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation.

Categories / Uncategorized

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

Loading...